of the investors from within October 31, 2018 to be on November 30, 2018. 2) Adding information relating to investors, shareholding structure before and after the allocation of newly-issued ordinary
deemed as acquisition or disposal of assets, and the notification of the Board of Governor of the Stock Exchange of Thailand Re: Disclosure of information and other acts of listed companies concerning the
or Other Assets for Management Company dated 9 September 1999; (3) Notification of the Office of the Securities and Exchange Commission No. SorNor. 33/2543 Re: Acts that may Create Conflict of Interest
Interest on Investment or Holding of Securities or Other Assets for Management Company dated 9 September 1999; (3) Notification of the Office of the Securities and Exchange Commission No. SorNor. 33/2543 Re
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
allocation of personnel related expenses from Products and Solution members in Q1/2016 at the amount of 1.78 million THB. However, the proportion of selling expenses to total revenue is decreased from 4.95% to
over CAZ. The transaction is considered the disposition of assets in accordance with the Notification of the Capital Market Supervisory Board No. Tor Chor 20/2551 re: Rules on Entering into Materials